- Associate Professor, Department of Oncology, Queen's University
- Department of Public Health Sciences, Queen’s University, cross-appointment
- Primary Investigator, Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University
- Radiation Oncologist, Cancer Centre of Southeastern Ontario
- Ontario Institute for Cancer Research (OICR) Clinician Scientist Tier I
- ICES Adjunct Scientist
- Clinician-Scientist, Cancer Centre of Southeastern Ontario
Dr. Timothy Hanna is a clinician scientist at the Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen’s University, Kingston, Ontario, Canada. He is also a radiation oncologist at the Cancer Centre of Southeastern Ontario. His work focuses on health services research in oncology, with three translational streams: quality of care, value of care and access to care. His value of care research touches on health technology assessment in the real-world, particularly for novel therapies (e.g. radiotherapy, ‘omics driven personalized medicine, immunotherapy). Methods include machine learning approaches, and often use large, complex data sets.
He received his PhD and Fellowship training at the Collaboration for Cancer Outcomes Research and Evaluation (CCORE) at Liverpool Hospital in Sydney, Australia (2010-2012). He developed models of population benefit of optimal radiotherapy utilization as part of his PhD thesis work and fellowship there, working with Prof M Barton, Prof G Delaney and Dr. J Shafiq. Prior to this, he trained at Queen’s University in Radiation Oncology and completed an MSc with Dr. WJ Mackillop, focusing on barriers to access to radiation and its impact on cancer outcomes for endometrial cancer. Dr. Hanna obtained his MD at the University of Toronto.
- Cancer health services research
- Access to cancer therapy, prioritization, value of care
- Population-based outcomes of novel cancer therapies
- Global health and oncology
Dr. Hanna's publications are available on PubMed.